Journal of Neuroscience,
Год журнала:
2018,
Номер
38(12), С. 2911 - 2919
Опубликована: Март 21, 2018
Microglia
are
emerging
as
key
players
in
neurodegenerative
diseases,
such
Alzheimer's
disease
(AD).
Thus
far,
microglia
have
rather
been
known
modulator
of
neurodegeneration
with
functions
limited
to
neuroinflammation
and
release
neurotoxic
molecules.
However,
several
recent
studies
demonstrated
a
direct
role
"neuro"
degeneration
observed
AD
by
promoting
phagocytosis
neuronal,
particular,
synaptic
structures.
While
some
the
address
involvement
β-amyloid
peptides
process,
also
indicate
that
this
could
occur
independent
amyloid,
further
elevating
importance
AD.
Here
we
review
these
speculate
about
possible
cellular
mechanisms,
how
they
be
regulated
risk
genes
sleep.
Finally,
deliberate
on
avenues
for
targeting
microglia-mediated
synapse
loss
therapy
prevention.Dual
Perspectives
Companion
Paper:
Disease
Sleep-Wake
Disturbances:
Amyloid,
Astrocytes,
Animal
Models
William
M.
Vanderheyden,
Miranda
Lim,
Erik
S.
Musiek,
Jason
R.
Gerstner.
Molecular Neurodegeneration,
Год журнала:
2020,
Номер
15(1)
Опубликована: Июль 16, 2020
Abstract
Alzheimer’s
disease
(AD)
is
the
most
common
neurodegenerative
disorder
seen
in
age-dependent
dementia.
There
currently
no
effective
treatment
for
AD,
which
may
be
attributed
part
to
lack
of
a
clear
underlying
mechanism.
Studies
within
last
few
decades
provide
growing
evidence
central
role
amyloid
β
(Aβ)
and
tau,
as
well
glial
contributions
various
molecular
cellular
pathways
AD
pathogenesis.
Herein,
we
review
recent
progress
with
respect
Aβ-
tau-associated
mechanisms,
discuss
dysfunction
emphasis
on
neuronal
receptors
that
mediate
Aβ-induced
toxicity.
We
also
other
critical
factors
affect
pathogenesis,
including
genetics,
aging,
variables
related
environment,
lifestyle
habits,
describe
potential
apolipoprotein
E
(APOE),
viral
bacterial
infection,
sleep,
microbiota.
Although
have
gained
much
towards
understanding
aspects
this
devastating
disorder,
greater
commitment
research
mechanism,
diagnostics
will
needed
future
research.
Journal of Alzheimer s Disease,
Год журнала:
2018,
Номер
64(s1), С. S567 - S610
Опубликована: Июнь 12, 2018
The
amyloid-
oligomer
(AO)
hypothesis
was
introduced
in
1998.It
proposed
that
the
brain
damage
leading
to
Alzheimer's
disease
(AD)
instigated
by
soluble,
ligand-like
AOs.This
based
on
discovery
fibril-free
synthetic
preparations
of
AOs
were
potent
CNS
neurotoxins
rapidly
inhibited
long-term
potentiation
and,
with
time,
caused
selective
nerve
cell
death
(Lambert
et
al.,
1998).The
mechanism
attributed
disrupted
signaling
involving
tyrosine-protein
kinase
Fyn,
mediated
an
unknown
toxin
receptor.Over
4,000
articles
concerning
have
been
published
since
then,
including
more
than
400
reviews.AOs
shown
accumulate
AD-dependent
manner
human
and
animal
model
tissue
experimentally,
impair
learning
memory
instigate
major
facets
AD
neuropathology,
tau
pathology,
synapse
deterioration
loss,
inflammation,
oxidative
damage.As
reviewed
Hayden
Teplow
2013,
AO
"has
all
but
supplanted
amyloid
cascade."Despite
emerging
understanding
role
played
pathogenesis,
not
yet
received
clinical
attention
given
plaques,
which
at
core
attempts
therapeutics
diagnostics
are
no
longer
regarded
as
most
pathogenic
form
A.However,
if
momentum
research
continues,
particularly
efforts
elucidate
key
aspects
structure,
a
clear
path
successful
modifying
therapy
can
be
envisioned.Ensuring
lessons
learned
from
recent,
late-stage
failures
applied
appropriately
throughout
therapeutic
development
will
further
enable
likelihood
near-term.
Science,
Год журнала:
2016,
Номер
354(6315), С. 1004 - 1008
Опубликована: Ноя. 24, 2016
Disruptions
of
normal
circadian
rhythms
and
sleep
cycles
are
consequences
aging
can
profoundly
affect
health.
Accumulating
evidence
indicates
that
disturbances,
which
have
long
been
considered
symptoms
many
neurodegenerative
conditions,
may
actually
drive
pathogenesis
early
in
the
course
these
diseases.
In
this
Review,
we
explore
potential
cellular
molecular
mechanisms
linking
dysfunction
loss
to
diseases,
with
a
focus
on
Alzheimer’s
disease.
We
examine
interplay
between
central
peripheral
rhythms,
clock
gene
function,
maintaining
brain
homeostasis,
discuss
therapeutic
implications.
The
influence
number
key
processes
involved
neurodegeneration,
suggesting
systems
might
be
manipulated
promote
healthy
aging.
JAMA Neurology,
Год журнала:
2013,
Номер
70(5), С. 587 - 587
Опубликована: Март 11, 2013
Sleep
and
circadian
problems
are
very
common
in
Alzheimer
disease
(AD).
Recent
animal
studies
suggest
a
bidirectional
relationship
between
sleep
β-amyloid
(Aβ),
key
molecule
involved
AD
pathogenesis.To
test
whether
Aβ
deposition
preclinical
AD,
prior
to
the
appearance
of
cognitive
impairment,
is
associated
with
changes
quality
or
quantity
sleep.Cross-sectional
study
conducted
from
October
2010
June
2012.General
community
volunteers
at
Washington
University
Knight
Alzheimer's
Disease
Research
Center.Cognitively
normal
individuals
(n
=
145)
45
years
older
were
recruited
longitudinal
memory
aging
Center.
Valid
actigraphy
data
recorded
142.
The
majority
(124
142)
Adult
Children
Study,
which
all
aged
75
baseline
50%
have
parental
history
late-onset
AD.
rest
volunteer
cohort
than
60
healthy
baseline.Sleep
was
objectively
measured
using
for
2
weeks.
efficiency,
percentage
time
bed
spent
asleep,
primary
measure
quality.
Total
quantity.
Cerebrospinal
fluid
Aβ42
levels
used
determine
amyloid
present
absent.
Concurrent
diaries
provided
nap
information.Amyloid
deposition,
as
assessed
by
levels,
32
participants
(22.5%).
This
group
had
worse
quality,
efficiency
(80.4%
vs
83.7%),
compared
those
without
after
correction
age,
sex,
APOEε4
allele
carrier
status
(P
.04).
In
contrast,
not
significantly
different
groups,
total
time.
Frequent
napping,
3
more
days
per
week,
(31.2%
14.7%;
P
.03).Amyloid
stage
appears
be
but